Skip to content

Comparison of Immediate Effects of Different Shoulder Stretching Techniques in Overhead Athletes

Comparison of Immediate Effects of Different Posterior Shoulder Stretching Techniques in Overhead Athletes With Glenohumeral Internal Rotation Deficits

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04687683
Enrollment
81
Registered
2020-12-29
Start date
2023-02-01
Completion date
2024-12-01
Last updated
2023-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glenohumeral Internal Rotation Deficit

Brief summary

81 overhead athletes with Glenohumeral Internal Rotation Deficit (GIRD) will be included in this study. Participants will be randomly divided into 3 different groups of 26 people. In each group will be applied posterior shoulder stretching exercises (PSSE) performed with different Muscle Energy Techniques (MET).

Detailed description

Post Isometric Relaxation Group (PIRG) participants will perform a PSSE with post isometric relaxation (PIR) technique, Isolytic Stretching Group (ISG) participants will perform a PSSE with isolytic stretching technique and Static Stretching Group Group (SSG) participants will perform a PSSE with static stretching technique. All exercises will be performed in the modified cross-body position. Subacromial space and posterior capsule thickness will be measured using a 7-12 MHz linear transducer with USG (LOGIQ e Ultrasound, GE Healthcare, USA). Athletes' GIRD results and rotational ROM measurements will be measured and recorded using a bubble inclinometer (Fabrication End Inc, New York, USA). The upper extremity functional performance of the athletes will be evaluated with the Functional Throwing Performance Index (FTPI). Evaluations will be repeated tree times before, after the stretching exercise and 30 minutes later and the effects of different muscle energy techniques (MET) will be compared. Investigators hypothesized PSSE made with different MET techniques have different effects on Acromio-Humeral Distance, posterior capsule thickness, rotational ROM measurements and performance on overhead athletes with GIRD and the effects of MET would be superior to static stretching.

Interventions

Athletes will be positioned in a modified cross-body position. They will be asked to actively bring their underlying arm in the direction of horizontal adduction up to the physiological barrier barrier. The participants will be asked to perform an isometric contraction for 5 seconds in the horizontal abduction direction with 20% of the maximum muscle strength. After the relaxation, the arm will be moved towards horizontal adduction and 15 seconds active-assistive stretching will be applied. Participants will be given a 5-second rest period between contractions. This stretching exercise will be applied in 5 repetitions for one session.

Athletes will be positioned in a modified cross-body position. They will be asked to actively bring their underlying arm in the direction of horizontal adduction up to the physiological barrier barrier. The participants will be asked to perform a contraction in the horizontal abduction direction with 20% of the maximum muscle strength. When the muscle contraction occurs, the arm will be moved quickly in 2-4 seconds towards horizontal adduction and 15 seconds active-assistive stretching will be applied. Participants will be given a 5-second rest period between stretches. This stretching exercise will be applied in 5 repetitions for one session.

Athletes will be positioned in a modified cross-body position. They will be asked to actively bring their underlying arm in the direction of horizontal adduction up to the physiological barrier. Then, the arm will be moved towards horizontal adduction and 15 seconds active-assistive stretching will be applied. Participants will be given a 5-second rest period between stretching exercises. This stretching exercise will be applied in 5 repetitions for one session.

Sponsors

Dokuz Eylul University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
13 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Being overhead athlete * Glenohumeral internal rotation range of motion of the affected shoulder should be less than other shoulder and bilateral shoulder internal rotation range of motion difference should be ≥15 º

Exclusion criteria

* Shoulder pain required medical attention for the last year. * Current shoulder pain * Cervical pain during upper extremity movement * History of fracture to the shoulder girdle * Systemic musculoskeletal disease * History of shoulder surgery, * Glenohumeral instability (positive apprehension, relocation, or positive sulcus test) or positive findings for a full thickness rotator cuff tear (positive lag sign, positive drop arm test, or marked weakness with shoulder external rotation)

Design outcomes

Primary

MeasureTime frameDescription
Shoulder internal rotation range of motionbaseline measurements, 3 minutes and 30 minutesChange of shoulder internal rotation range of motion (with bubble inclinometer)

Secondary

MeasureTime frameDescription
Subacromial spacebaseline measurements, 3 minutes and 30 minutesChange of subacromial space ( with Ultrasound)
Posterior capsule thicknessbaseline measurements, 3 minutes and 30 minutesChange of posterior capsule thickness ( with Ultrasound)
Functional Throwing Performance Indexbaseline measurements, 3 minutes and 30 minutesParticipants will throw a ball to shot a frame on a wall. Number of correct shots will be recorded
Shoulder Total rotation range of motionbaseline measurements, 3 minutes and 30 minutesChange of shoulder internal rotation + external rotation range of motion (with bubble inclinometer)
Posterior shoulder tightnessbaseline measurements, 3 minutes and 30 minutesChange of posterior shoulder tightness (with bubble inclinometer)

Contacts

Primary ContactGonca Sahiner Pıçak, MSc
gncshnr@gmail.com+905058081268

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026